Amarin continues to lose market share in the U.S. as it faces stiff competition from generic drug-makers. Find out why I maintain a sell rating on AMRN.
Amarin Corp. (AMRN) Announces Latest Research Evaluating VASCEPA/VAZKEPA and Subgroups from REDUCE-IT Landmark Outcomes Trial to be Presented at ESC Congress streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Investegate announcements from Amarin Corporation plc, REDUCE-IT Exploratory Post Hoc Biomarker Sub-Analysis Shows Relatively Small Changes in Inflammatory Markers Between Icosapent Ethyl and Placebo
Amarin Corp. (AMRN) Announces REDUCE-IT Exploratory Post Hoc Biomarker Sub-Analysis Shows Relatively Small Changes in Inflammatory Markers Between Icosapent Ethyl and Placebo streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.